Dataset extent
Pharmaceutical emissions to the Baltic Sea
Data and Resources
Additional Info
Field | Value |
---|---|
File Identifier | {1D85D79E-ADCC-4726-AFA2-742AED0F212A} |
Metadata Language | eng |
Organisation responsible for metadata | Suomen ympäristökeskus |
Contact information of the organisation responsible for metadata | gistuki.syke@ymparisto.fi |
The role of the organisation responsible for metadata | pointOfContact |
Metadata revision date | 2022-12-08 |
EPSG Code of the Reference System, see https://epsg.io/ | EPSG:3035 |
Service Date | 2020-12-18 |
Service Date Type | publication |
Unique Resource identifier of Service | |
Organisation Responsible for Service | Suomen ympäristökeskus |
Contact information of the organisation responsible for Service | gistuki.syke@ymparisto.fi |
The role of the organisation responsible for Service | pointOfContact |
Other keywords | humanGeographicViewer |
Other keywords: Thesaurus name | Commission Regulation (EC) No 1205/2008 of 3 December 2008 implementing Directive 2007/2/EC of the European Parliament and of the Council as regards metadata |
GEMET Concepts Keyword | on-line service |
Resource Classification | Karttapalvelu |
Service Category | Ei-Inspire |
Other keywords | Ei-Inspire |
Other keywords: Thesaurus name | |
Use constraints and source | Creative Commons Nimeä 4.0 Kansainvälinen http://www.syke.fi/fi-FI/Avoin_tieto/Kayttolupa_ja_vastuut Source: Syke, Äystö, L., Siimes, K., Junttila, V., Joukola, M., Liukko, N. 2020. Emissions and environmental levels of pharmaceuticals – Upscaling to the Baltic Sea Region. Project CWPharma activity 2.3 report. https://hdl.handle.net/10138/321722 |
Access Constraints | no limitations |
Service Type | view |
Begin Date of Temporal Extent | None |
End Date of Temporal Extent | None |
Lineage Information of Service | More information on the calculation tool & results: Äystö, L., Siimes, K., Junttila, V., Joukola, M., Liukko, N. 2020. Emissions and environmental levels of pharmaceuticals – Upscaling to the Baltic Sea Region. Project CWPharma activity 2.3 report. http://hdl.handle.net/10138/321722 |